| Active ingredient (INN) | Furosemide |
|---|---|
| ATC level 5 | C03CA01 |
| ATC level 4 | C03CA |
| Therapeutic category | Auto-created by U.S. Food and Drug Administration — Drug Shortages scraper |
| WHO Essential Medicine | Yes (2023) |
| Controlled substance | No |
| Marketing-authorisation holders | Alphapharm Pty Ltd, Ipca Pharma (Australia) Pty Ltd, BAXTER HEALTHCARE LIMITED, ACCORD-UK LIMITED +7 more |
| Registrations on file | 26 |
| Patient information leaflet (PIL) | Not on file |
| Summary of product characteristics (SPC) | Not on file |
| Product | Strength | Form | Market | MA holder | Status |
|---|---|---|---|---|---|
| Noumed | 40 mg | — | 🇦🇺 AU | — | Active |
| Uremide | 20 mg | — | 🇦🇺 AU | Alphapharm Pty Ltd | Active |
| FRUSIPCA furosemide | 20 mg | — | 🇦🇺 AU | Ipca Pharma (Australia) Pty Ltd | Active |
| Furo Ipca furosemide | 20 mg | — | 🇦🇺 AU | Ipca Pharma (Australia) Pty Ltd | Active |
| I | 20 mg | — | 🇦🇺 AU | Ipca Pharma (Australia) Pty Ltd | Active |
| Ip | 20 mg | — | 🇦🇺 AU | Ipca Pharma (Australia) Pty Ltd | Active |
| Frusipca furosemide | 40 mg | — | 🇦🇺 AU | Ipca Pharma (Australia) Pty Ltd | Active |
| Furo Ipca furosemide | 40 mg | — | 🇦🇺 AU | Ipca Pharma (Australia) Pty Ltd | Active |
| I | 40 mg | — | 🇦🇺 AU | Ipca Pharma (Australia) Pty Ltd | Active |
| Ip | 40 mg | — | 🇦🇺 AU | Ipca Pharma (Australia) Pty Ltd | Active |
| FUROSEMIDE 10 MG/ML SOLUTION FOR INJECTION | 10 MG | injection | 🇬🇧 GB | BAXTER HEALTHCARE LIMITED | Active |
| Furosemide Tablets Bp | 20MG | tablet | 🇬🇧 GB | ACCORD-UK LIMITED | Active |
| Furosemide Tablets Bp | 500MG | tablet | 🇬🇧 GB | ACCORD-UK LIMITED | Active |
| Furosemide Tablets Bp | 40MG | tablet | 🇬🇧 GB | ACCORD-UK LIMITED | Active |
| Furosemide Injection Bp | — | injection | 🇬🇧 GB | HAMELN PHARMA LTD | Active |